Rowland & CO Investment Counsel Bio Techne Corp Transaction History

Rowland & CO Investment Counsel

$472 Million
Q4 2024

A detailed history of Rowland & CO Investment Counsel transactions in Bio Techne Corp stock. As of the latest transaction made, Rowland & CO Investment Counsel holds 40,490 shares of TECH stock, worth $2.6 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

40,490

Previous 41,070 1.41%

Holding current value

$2.6 Million

Previous $3.28 Million 11.12%

% of portfolio

0.62%

Previous 0.68%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	SELL	$66.37 - $78.17 $38,494 - $45,338	-580 Reduced 1.41%	40,490 $2.92 Million
Q2 2024 Jul 29, 2024	SELL	$62.12 - $84.15 $401,605 - $544,029	-6,465 Reduced 13.6%	41,070 $2.94 Million
Q1 2024 Apr 08, 2024	SELL	$65.98 - $77.09 $29,031 - $33,919	-440 Reduced 0.92%	47,535 $3.35 Million
Q4 2023 Jan 03, 2024	SELL	$52.83 - $78.22 $61,282 - $90,735	-1,160 Reduced 2.36%	47,975 $3.7 Million
Q2 2023 Aug 04, 2023	SELL	$73.76 - $85.98 $74,497 - $86,839	-1,010 Reduced 2.01%	49,135 $4.01 Million
Q1 2023 Apr 25, 2023	SELL	$71.62 - $86.62 $19,695 - $23,820	-275 Reduced 0.55%	50,145 $3.72 Million
Q4 2022 Jan 04, 2023	BUY	$80.67 - $352.29 $3.01 Million - $13.2 Million	37,350 Added 285.77%	50,420 $0
Q1 2022 Apr 26, 2022	SELL	$353.85 - $487.79 $298,649 - $411,694	-844 Reduced 6.07%	13,070 $5.66 Million
Q4 2021 Feb 14, 2022	SELL	$456.15 - $525.06 $1.13 Million - $1.31 Million	-2,488 Reduced 15.17%	13,914 $7.2 Million
Q3 2021 Nov 08, 2021	BUY	$444.87 - $538.88 $891,964 - $1.08 Million	2,005 Added 13.93%	16,402 $7.95 Million
Q2 2021 Aug 09, 2021	SELL	$387.35 - $450.26 $38,735 - $45,026	-100 Reduced 0.69%	14,397 $6.48 Million
Q1 2021 May 11, 2021	SELL	$314.62 - $411.0 $388,555 - $507,585	-1,235 Reduced 7.85%	14,497 $5.54 Million
Q4 2020 Feb 11, 2021	SELL	$246.9 - $321.87 $190,113 - $247,839	-770 Reduced 4.67%	15,732 $5 Million
Q3 2020 Nov 12, 2020	BUY	$232.22 - $282.96 $23,222 - $28,295	100 Added 0.61%	16,502 $4.09 Million
Q2 2020 Aug 10, 2020	SELL	$185.43 - $279.56 $18,543 - $27,956	-100 Reduced 0.61%	16,402 $4.33 Million
Q1 2020 May 11, 2020	SELL	$161.17 - $221.51 $112,818 - $155,057	-700 Reduced 4.07%	16,502 $3.13 Million
Q4 2019 Jan 28, 2020	BUY	$189.68 - $222.09 $75,872 - $88,836	400 Added 2.38%	17,202 $3.78 Million
Q3 2019 Oct 02, 2019	SELL	$183.56 - $216.72 $9,178 - $10,836	-50 Reduced 0.3%	16,802 $3.29 Million
Q2 2019 Jul 09, 2019	SELL	$188.72 - $215.43 $45,292 - $51,703	-240 Reduced 1.4%	16,852 $0
Q1 2019 Apr 10, 2019	SELL	$136.09 - $200.44 $4,490 - $6,614	-33 Reduced 0.19%	17,092 $0
Q4 2018 Feb 12, 2019	BUY	$132.75 - $203.8 $20,576 - $31,589	155 Added 0.91%	17,125 $2.48 Million
Q3 2018 Oct 22, 2018	SELL	$147.44 - $204.11 $92,150 - $127,568	-625 Reduced 3.55%	16,970 $0
Q2 2018 Jul 11, 2018	SELL	$144.9 - $165.58 $21,735 - $24,837	-150 Reduced 0.85%	17,595 $0
Q1 2018 Apr 17, 2018	SELL	$131.46 - $151.04 $292,498 - $336,064	-2,225 Reduced 11.14%	17,745 $0
Q4 2017 Jan 11, 2018	SELL	$121.17 - $134.75 $101,298 - $112,651	-836 Reduced 4.02%	19,970 $0
Q3 2017 Oct 11, 2017	SELL	$113.59 - $123.78 $124,267 - $135,415	-1,094 Reduced 5.0%	20,806 $0
Q3 2017 Oct 11, 2017	BUY	$113.59 - $123.78 $2.49 Million - $2.71 Million	21,900	21,900 $0

Others Institutions Holding TECH

# of Institutions

615

Shares Held

156M

Call Options Held

161K

Put Options Held

12.7K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.52B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rowland & CO Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Rowland & CO Investment Counsel with notifications on news.

Account

Rowland & CO Investment Counsel Bio Techne Corp Transaction History